Menu

An Editorial Mission: CRISPR Targets Animal Models

Download this eBook from The Scientist and Synthego to find out about CRISPR's translational potential in generating transgenic animals and where it can take you in the future!

Nov 6, 2017
The Scientist Creative Services Team

CRISPR genome-editing technology is only five years old, but it has already made remarkable strides in biomedical, microbial, and agricultural research. CRISPR affords scientists the ability to edit multiple genes at once in any extant organism, which is especially relevant for generating in vivo model systems for pathologies like cancer. With CRISPR, researchers can now easily tailor the genome of an organism to suit their needs, with minimal prior animal model development experience required.

Download this eBook from The Scientist to learn about:
 • How CRISPR works and its translational potential
 • The steps to generating a new transgenic animal model using CRISPR
 • CRISPR's place in the transgenic toolkit
 • Where CRISPR has already gone, and where it can go in the future

This free eBook was made possible by an educational grant from Synthego.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.